Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of albumin administration for prevention of fluid creep in severe burn patients
IRCT20210227050510N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of albumin (human) in burn injury (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Fluid intake to maintain satisfactory urine output and Incidence of fluid creep. Started Jul 2021; status: completed.
02
Drugs
albumin (human)
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20210227050510N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210227050510N1.